ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.27
0.79%
Dow Jones
43,870.35
1.06%
Gold vs US Dollar
2,688.225
0.71%
Brent Oil
73.915
-0.02%
Bitcoin
98,882.07
0.37%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xenon Pharmaceuticals Inc (XENE)

  7. Xenon Pharmaceuticals Inc (XENE) News

Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XENE
DateTimeSourceHeadlineSymbolCompany
13/11/202421:01GlobeNewswire Inc.Xenon to Present at Upcoming Investor ConferencesNASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202421:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202421:01GlobeNewswire Inc.Xenon Reports Q3 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
05/11/202421:01GlobeNewswire Inc.Xenon to Report Q3 2024 Financial Results on November 12, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
02/10/202420:28GlobeNewswire Inc.Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
09/09/202412:30GlobeNewswire Inc.Xenon Showcases Azetukalner Data at 15th European Epilepsy CongressNASDAQ:XENEXenon Pharmaceuticals Inc
12/08/202412:30GlobeNewswire Inc.Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating OfficerNASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202420:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202420:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202420:01GlobeNewswire Inc.Xenon Reports Q2 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
01/08/202420:01GlobeNewswire Inc.Xenon to Report Q2 2024 Financial Results on August 8, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202401:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202401:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
12/06/202421:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202420:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202420:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202420:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
28/05/202412:30GlobeNewswire Inc.Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202420:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202420:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202420:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
07/05/202420:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XENE

Your Recent History

LSE
RBD
Reabold Resources
LSE
FAR
Ferro-alloy Resources
LSE
EDEN
Eden Research
LSE
GKP
Gulf Keystone Petroleum
LSE
LLOY
Lloyds Banking
LSE
EME
Empyrean Energy
LSE
NEXN
Nexxen
LSE
ITM
Itm Power
LSE
QBT
Quantum Blockchain Techn...
LSE
SGRO
Segro
LSE
MNL
Manchester & London Inve...
LSE
POLX
Polarean Imaging
LSE
SNG
Synairgen
LSE
GPM
Golden Prospect Precious...
LSE
BARC
Barclays
LSE
STX
Shield Therapeutics
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06